Long COVID
Coverage of Long COVID in the Nexus archive.
- Inside Health
Millions of people continue to experience long Covid, but a cure remains elusive. The article highlights the ongoing challenge of finding a solution for those affected by the condition.
- STAT+: Federal health quality research grants worth $109 million ended early
Federal health research grants worth $109 million were terminated early by the Agency for Healthcare Research and Quality (AHRQ), affecting 78 grants totaling $200 million. Researchers received notices citing a shift in priorities to focus on areas like patient safety, AI, long Covid, and autism. AcademyHealth confirmed the impact on health services researchers, who expressed concerns about their field's future.
- Common antidepressant may ease long COVID’s crushing fatigue
A low-cost antidepressant, fluvoxamine, significantly reduced long COVID fatigue and improved quality of life in a randomized clinical trial involving 399 adults. The study found it outperformed a placebo, marking one of the first medications to show meaningful benefits for long COVID.
- Long Covid May Physically Damage the Nerves That Control the Stomach
Long Covid may cause physical damage to the nerves controlling the stomach, according to a study. The research is published in the International Journal of Infectious Diseases.
- Opinion: How long Covid’s scientific stalemate made it politically erasable
Mitchell Miglis, a Stanford neurology professor, had his NIH-funded long Covid research grant terminated as incompatible with agency priorities, leading to criticism about the impact on scientific progress and patient care.
- The Causes of Long Covid
The article discusses potential causes of Long Covid, a condition where symptoms persist after initial infection. It highlights ongoing research into understanding the mechanisms behind prolonged symptoms.
- Hyperbaric oxygen therapy is being explored as a long COVID treatment. Here’s what the research shows
Hyperbaric oxygen therapy is being explored as a potential treatment for long COVID, with some clinics promoting pressurized oxygen chambers. However, the evidence supporting its effectiveness remains mixed.
- The Painful Truth About Long Covid
The article discusses a potential breakthrough in long Covid treatment, suggesting a way forward. However, it highlights a conditional barrier to discussing the treatment openly.
- The latest developments on Ebola, hepatitis B, long Covid
The article promotes STAT’s free daily health newsletter 'Morning Rounds,' highlighting topics like Ebola, hepatitis B, and long Covid. It includes a call to sign up and mentions the author’s personal reading distractions.
- Scientists thought brain inflammation was driving long COVID but the scans told a different story
A new brain imaging study found no evidence of widespread brain inflammation in long COVID patients. Instead, severe symptoms were linked to increased activity in brain regions associated with mood and emotion.
- Innovation will provide solutions to Long COVID — the new chronic disease of our time
Long COVID affects an estimated 18 million Americans and is a growing public health crisis, with Senator Todd Young pushing for more research and Secretary Kennedy committing to continue efforts to identify biomarkers. The disease causes various symptoms, including cognitive dysfunction and extreme fatigue. There is currently no molecular diagnostic test or definitive therapy.
- 'My daughter spends 70 per cent of her day in bed. I would give anything to make her better again': Inside the forgotten epidemic of long Covid - but a major breakthrough is on the horizon for the millions of sufferers
The article highlights the severe impact of long Covid on families, with a parent describing their child's 70% bedridden condition, while noting a potential breakthrough in treatments for the millions affected.